Matthias H Munk
Overview
Explore the profile of Matthias H Munk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
277
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Blomeke L, Rehn F, Kraemer-Schulien V, Kutzsche J, Pils M, Bujnicki T, et al.
Alzheimers Dement (Amst)
. 2024 Apr;
16(2):e12589.
PMID: 38666085
Introduction: Soluble amyloid beta (Aβ) oligomers have been suggested as initiating Aβ related neuropathologic change in Alzheimer's disease (AD) but their quantitative distribution and chronological sequence within the AD continuum...
12.
A generalizable data-driven model of atrophy heterogeneity and progression in memory clinic settings
Baumeister H, Vogel J, Insel P, Kleineidam L, Wolfsgruber S, Stark M, et al.
Brain
. 2024 Apr;
147(7):2400-2413.
PMID: 38654513
Memory clinic patients are a heterogeneous population representing various aetiologies of pathological ageing. It is not known whether divergent spatiotemporal progression patterns of brain atrophy, as previously described in Alzheimer's...
13.
Deike K, Decker A, Scheyhing P, Harten J, Zimmermann N, Paech D, et al.
Invest Radiol
. 2024 Apr;
59(9):667-676.
PMID: 38652067
Objectives: Impaired perivascular clearance has been suggested as a contributing factor to the pathogenesis of Alzheimer disease (AD). However, it remains unresolved when the anatomy of the perivascular space (PVS)...
14.
Martinelli F, Heinken A, Henning A, Ulmer M, Hensen T, Gonzalez A, et al.
Sci Rep
. 2024 Mar;
14(1):6095.
PMID: 38480804
In this study, we aimed to understand the potential role of the gut microbiome in the development of Alzheimer's disease (AD). We took a multi-faceted approach to investigate this relationship....
15.
Hayek D, Ziegler G, Kleineidam L, Brosseron F, Nemali A, Vockert N, et al.
Mol Psychiatry
. 2024 Jan;
29(4):992-1004.
PMID: 38216727
Neuroinflammation is a hallmark of Alzheimer's disease (AD) and both positive and negative associations of individual inflammation-related markers with brain structure and cognitive function have been described. We aimed to...
16.
Teipel S, Dyrba M, Kleineidam L, Brosseron F, Levin F, Bruno D, et al.
Alzheimers Dement (Amst)
. 2024 Jan;
16(1):e12510.
PMID: 38213951
Introduction: We investigated the association of inflammatory mechanisms with markers of Alzheimer's disease (AD) pathology and rates of cognitive decline in the AD spectrum. Methods: We studied 296 cases from...
17.
Teipel S, Dyrba M, Levin F, Altenstein S, Berger M, Beyle A, et al.
J Alzheimers Dis Rep
. 2023 Oct;
7(1):1055-1076.
PMID: 37849637
Background: Cognitive decline is a key outcome of clinical studies in Alzheimer's disease (AD). Objective: To determine effects of global amyloid load as well as hippocampus and basal forebrain volumes...
18.
Stark M, Wolfsgruber S, Kleineidam L, Frommann I, Altenstein S, Bartels C, et al.
Neurology
. 2023 Oct;
101(21):e2185-e2196.
PMID: 37821235
Background And Objectives: To determine the relevance of minor neuropsychological deficits (MNPD) in patients with subjective cognitive decline (SCD) with regard to CSF levels of Alzheimer disease (AD) biomarkers, cognitive...
19.
Waschkies K, Soch J, Darna M, Richter A, Altenstein S, Beyle A, et al.
Int J Geriatr Psychiatry
. 2023 Oct;
38(10):e6007.
PMID: 37800601
Background: Alzheimer's disease (AD) is often preceded by stages of cognitive impairment, namely subjective cognitive decline (SCD) and mild cognitive impairment (MCI). While cerebrospinal fluid (CSF) biomarkers are established predictors...
20.
Martinelli F, Heinken A, Henning A, Worheide M, Hensen T, Gonzalez A, et al.
Res Sq
. 2023 Sep;
PMID: 37720019
In this study, we aimed to understand the potential role of the gut microbiome in the development of Alzheimer's disease (AD). We took a multi-faceted approach to investigate this relationship....